- Details
- Derya Tilki discusses the complexities of managing pathologic node-positive (pN1) disease in prostate cancer. Dr. Tilki highlights the increasing rates of patients with positive lymph nodes at radical prostatectomy and explores various postoperative management strategies, including observation, androgen deprivation therapy (ADT), and adjuvant radiation. She emphasizes the heterogeneity of pN1 dise...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Alberto Briganti presents the disadvantages of using novel imaging in the management of non-metastatic castrate-resistant prostate cancer (nmCRPC) patients. Biographies: Alberto Briganti, MD, PhD, Associate Professor of Urology, San Raffaele, Milan, Italy Related Content: APCCC 2022: Disadvantages of Using Novel Imag...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Michael Morris presents on advantages of using novel imaging in nmCRPC. Biographies: Michael Morris, MD, Medical Oncologist Clinical Director, Genitourinary Medical Oncology Service & Prostate Cancer Section Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Relat...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Eleni Efstathiou presents an overview of treatment options for non-metastatic castrate-resistant prostate cancer. Biographies: Eleni Efstathiou, MD, PhD, Houston Methodist Hospital, Houston, TX Related Content: APCCC 2022: M0 CPRC: Overview of Treatment Options Read the Full Video Transcript {article id="138892"}{tex...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Fred Saad presents on the prevention of cardiovascular complications in advanced prostate cancer. Biographies: Fred Saad, MD, FRCS, Professor and Chief of Urology, Director of GU Oncology, Raymond Garneau Chair in Prostate Cancer, University of Montreal Hospital Centre (CHUM), Director, Prostate Cancer Research, Inst...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Jochen Walz presents on biochemical recurrence after definitive radiotherapy of the prostate focusing on local treatment options. Biographies: Jochen Walz, MD, Institut Paoli-Calmettes Cancer Center, Marseille, France Related Content: APCCC 2022: Biochemical Recurrence After Definitive Radiotherapy of the Prostate –...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Brandon Mahal presents on who needs systemic treatment with salvage radiotherapy. Biographies: Brandon Mahal, MD, University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL Related Content: APCCC 2022: Who Needs Systemic Treatment With Salvage RT? Read the Full Video Transcript {article...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Felix Feng presents how treatment for prostate cancer can be individualized by using genomic classifiers. Biographies: Felix Y. Feng, MD, Vice Chair of Faculty Development, Director of Translational Research, Department of Radiation Oncology, Director of the Benioff Institute for Prostate Cancer Research at the Unive...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Neha Vapiwala presents on PSA directed treatment for biochemical recurrence. Biographies: Neha Vapiwala, MD, FACR, FASTRO, Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA Related Content: APCCC 2022: Debate: PSA Directed Treatment for BCR APCCC 2022: Debate:...
|
- Details
- At the 2022 Advanced Prostate Cancer Consensus Conference (APCCC) Hybrid Meeting, Professor Nicholas James presents on imaging-directed treatment for biochemical recurrence. Biographies: Professor Nicholas James, MBBS, FRCP, FRCR, Ph.D., Professor of Clinical Oncology at the Institute of Cancer Research at Royal Marsden Hospital, London Related Content: APCCC 2022: Debate: Imaging Directed Treatme...
|
